Achieve Life Sciences Inc (ACHV)
4.85
-0.15
(-3.00%)
USD |
NASDAQ |
May 20, 10:37
Achieve Life Sciences Accounts Payable (Quarterly): 0.373M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.373M |
December 31, 2023 | 0.618M |
September 30, 2023 | 0.638M |
June 30, 2023 | 0.361M |
March 31, 2023 | 1.063M |
December 31, 2022 | 1.66M |
September 30, 2022 | 0.412M |
June 30, 2022 | 0.656M |
March 31, 2022 | 0.418M |
December 31, 2021 | 0.841M |
September 30, 2021 | 0.815M |
June 30, 2021 | 0.575M |
March 31, 2021 | 0.585M |
December 31, 2020 | 0.332M |
September 30, 2020 | 0.326M |
June 30, 2020 | 0.523M |
March 31, 2020 | 0.184M |
December 31, 2019 | 0.859M |
September 30, 2019 | 0.574M |
June 30, 2019 | 0.707M |
March 31, 2019 | 0.694M |
December 31, 2018 | 0.144M |
September 30, 2018 | 0.458M |
June 30, 2018 | 0.251M |
March 31, 2018 | 0.42M |
Date | Value |
---|---|
December 31, 2017 | 0.213M |
September 30, 2017 | 0.495M |
June 30, 2017 | 0.233M |
March 31, 2017 | 0.359M |
December 31, 2016 | 0.095M |
September 30, 2016 | 1.043M |
June 30, 2016 | 0.559M |
March 31, 2016 | 0.592M |
December 31, 2015 | 1.343M |
September 30, 2015 | 1.779M |
June 30, 2015 | 0.302M |
April 30, 2015 | 12.66M |
March 31, 2015 | 0.988M |
January 31, 2015 | 6.370M |
December 31, 2014 | 0.072M |
October 31, 2014 | 9.976M |
September 30, 2014 | 1.562M |
July 31, 2014 | 8.472M |
June 30, 2014 | 1.341M |
April 30, 2014 | 12.87M |
March 31, 2014 | 0.923M |
January 31, 2014 | 4.430M |
December 31, 2013 | 0.139M |
October 31, 2013 | 14.25M |
September 30, 2013 | 0.039M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.184M
Minimum
Mar 2020
1.66M
Maximum
Dec 2022
0.626M
Average
0.58M
Median
Accounts Payable (Quarterly) Benchmarks
Accelerate Diagnostics Inc | 5.108M |
Atossa Therapeutics Inc | 1.23M |
ENDRA Life Sciences Inc | 0.5216M |
Perspective Therapeutics Inc | 6.027M |
Electromed Inc | 0.792M |